GLYCERIN, LIDOCAINE

GLYCERIN, LIDOCAINE was reported 13939 times

GLYCERIN, LIDOCAINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACRIMAL DUCT PIGMENTATION 1 0.3333
1 APPLICATION SITE BLEEDING 45 0.1822
2 OCHLOPHOBIA 1 0.1429
3 ORAL HERPES 2423 0.1240
4 APPLICATION SITE ANAESTHESIA 8 0.1143
5 ERYTHROPOIETIN DEFICIENCY ANAEMIA 1 0.1111
6 HERPES SIMPLEX 706 0.1085
7 ORAL MUCOSAL SCAR 2 0.0909
8 APPLICATION SITE HYPOAESTHESIA 19 0.0812
9 APPLICATION SITE SCAR 101 0.0807
10 APPLICATION SITE SCAB 165 0.0763
11 PIGMENTATION LIP 8 0.0741
12 APPLICATION SITE HYPERAESTHESIA 7 0.0707
13 LIP HAEMORRHAGE 87 0.0682
14 APPLICATION SITE PARAESTHESIA 87 0.0667
15 APPLICATION SITE INFECTION 33 0.0648
16 DRUG ADMINISTRATION ERROR 1779 0.0579
17 LIP INFECTION 12 0.0566
18 LIP PAIN 147 0.0512
19 APPLICATION SITE SWELLING 208 0.0417
20 LIP SCAB 4 0.0412
21 APPLICATION SITE INDURATION 7 0.0412
22 LIP EXFOLIATION 48 0.0361
23 LIP ERYTHEMA 28 0.0350
24 LIP BLISTER 90 0.0330
25 APPLICATION SITE HAEMORRHAGE 88 0.0322
26 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 11 0.0303
27 APPLICATION SITE PALLOR 1 0.0303
28 LIP DISORDER 57 0.0301
29 LIP DISCOLOURATION 37 0.0293
30 INCORRECT DRUG ADMINISTRATION DURATION 803 0.0285
31 INCORRECT PRODUCT ADMINISTRATION DURATION 614 0.0283
32 CHEILITIS 145 0.0268
33 LIP PRURITUS 21 0.0245
34 CHAPPED LIPS 102 0.0235
35 INTRANASAL HYPOAESTHESIA 2 0.0213
36 REST REGIMEN 1 0.0208
37 HERNIA PERFORATION 2 0.0204
38 APPLICATION SITE PAIN 445 0.0202
39 APPLICATION SITE DRYNESS 68 0.0200
40 APPLICATION SITE DISCOLOURATION 81 0.0199
41 FUNCTIONAL RESIDUAL CAPACITY DECREASED 1 0.0196
42 APPLICATION SITE IRRITATION 231 0.0185
43 APPLICATION SITE DISCHARGE 21 0.0182
44 APPLICATION SITE REACTION 122 0.0173
45 LIP SWELLING 542 0.0163
46 PRODUCT PACKAGE ASSOCIATED INJURY 36 0.0161
47 APPLICATION SITE EXCORIATION 1 0.0154
48 BRONCHOMALACIA 2 0.0152
49 PRODUCT COMPLAINT 366 0.0144
50 APPLICATION SITE INFLAMMATION 19 0.0137
51 LIP DRY 124 0.0136
52 APPLICATION SITE VESICLES 87 0.0134
53 NERVE ROOT INJURY 1 0.0132
54 SUBMANDIBULAR MASS 1 0.0130
55 ALPHA-1 ANTI-TRYPSIN DEFICIENCY 1 0.0127
56 APPLICATION SITE PAPULES 13 0.0123
57 APPLICATION SITE WOUND 2 0.0121
58 ORAL DISCOMFORT 156 0.0112
59 APPLICATION SITE PUSTULES 4 0.0110
60 ALCOHOL TEST FALSE POSITIVE 1 0.0106
61 APPLICATION SITE INJURY 2 0.0105
62 BACTERIA URINE 1 0.0104
63 APPLICATION SITE EROSION 13 0.0101
64 APPLICATION SITE ULCER 7 0.0099
65 THERAPEUTIC PRODUCT EFFECT DELAYED 45 0.0099
66 PHARYNGOLARYNGEAL DISCOMFORT 1 0.0097
67 APPLICATION SITE LACERATION 4 0.0097
68 SWOLLEN TEAR DUCT 1 0.0094
69 APPLICATION SITE ERYTHEMA 246 0.0094
70 DRUG EFFECT FASTER THAN EXPECTED 3 0.0090
71 APPLICATION SITE EXFOLIATION 37 0.0090
72 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
73 APPLICATION SITE BURN 44 0.0089
74 APPLICATION SITE DISCOMFORT 16 0.0089
75 EMERGENCY CARE EXAMINATION 6 0.0088
76 NO ADVERSE DRUG EFFECT 6 0.0088
77 APPLICATION SITE WARMTH 11 0.0086
78 BLISTER RUPTURE 6 0.0081
79 CIRCUMORAL SWELLING 1 0.0078
80 SCAB 83 0.0073
81 INTENTIONAL DRUG MISUSE 151 0.0072
82 ADMINISTRATION SITE IRRITATION 1 0.0071
83 PENILE BURNING SENSATION 2 0.0070
84 BUCCAL MUCOSAL ROUGHENING 1 0.0070
85 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 491 0.0069
86 LIP INJURY 9 0.0069
87 DRUG EFFECT DELAYED 30 0.0066
88 HAEMORRHAGIC DIATHESIS 23 0.0065
89 CONDITION AGGRAVATED 1902 0.0062
90 ENDOMETRIAL CANCER METASTATIC 1 0.0062
91 LARYNGOMALACIA 2 0.0060
92 APPLICATION SITE PERSPIRATION 1 0.0058
93 MILIA 2 0.0055
94 EXAGGERATED STARTLE RESPONSE 1 0.0055
95 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0054
96 HYPOAESTHESIA FACIAL 8 0.0053
97 GINGIVAL INFLAMMATION 1 0.0053
98 NONSPECIFIC REACTION 29 0.0053
99 EXPIRED PRODUCT ADMINISTERED 171 0.0051
100 DYSPHORIA 26 0.0051
101 SKIN INFLAMMATION 1 0.0051
102 GINGIVAL ATROPHY 1 0.0051
103 IMPLANT SITE MASS 1 0.0051
104 TRACHEOMALACIA 2 0.0051
105 DRUG INEFFECTIVE 6670 0.0051
106 ARTHRITIS INFECTIVE 22 0.0047
107 PERIORAL DERMATITIS 3 0.0047
108 OEDEMA MOUTH 15 0.0046
109 SCAR 78 0.0046
110 THERAPEUTIC PRODUCT EFFECT VARIABLE 17 0.0044
111 PARAESTHESIA ORAL 63 0.0044
112 SWELLING FACE 284 0.0044
113 MALABSORPTION FROM ADMINISTRATION SITE 1 0.0043
114 GASTROSCHISIS 2 0.0042
115 INJECTION SITE NERVE DAMAGE 1 0.0042
116 MOLE EXCISION 1 0.0041
117 HYPOAESTHESIA ORAL 61 0.0040
118 EXPIRED DRUG ADMINISTERED 20 0.0040
119 PRODUCT QUALITY ISSUE 537 0.0039
120 APPETITE DISORDER 26 0.0039
121 APPLICATION SITE PRURITUS 87 0.0038
122 HERPES ZOSTER REACTIVATION 1 0.0038
123 SKIN WARM 22 0.0038
124 EXOMPHALOS 2 0.0037
125 SKIN LACERATION 40 0.0037
126 INTENTIONAL MISUSE 7 0.0037
127 MOUTH SWELLING 21 0.0036
128 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 66 0.0036
129 DRUG EFFECT VARIABLE 4 0.0035
130 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 100 0.0034
131 DRUG EFFECT LESS THAN EXPECTED 50 0.0034
132 GRUNTING 2 0.0033
133 AURICULAR SWELLING 2 0.0033
134 PERSISTENT FOETAL CIRCULATION 2 0.0033
135 APPLICATION SITE DERMATITIS 3 0.0032
136 DRUG ADMINISTERED AT INAPPROPRIATE SITE 32 0.0030
137 ORAL MUCOSAL DISCOLOURATION 2 0.0030
138 IODINE ALLERGY 1 0.0030
139 CIRCUMORAL OEDEMA 1 0.0029
140 RADIAL NERVE PALSY 1 0.0028
141 BURNING SENSATION MUCOSAL 1 0.0028
142 STAB WOUND 1 0.0028
143 ORAL DISCHARGE 1 0.0027
144 STOMAL HERNIA 1 0.0027
145 SALIVARY GLAND CALCULUS 1 0.0027
146 BLUNTED AFFECT 2 0.0027
147 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 540 0.0027
148 SENSATION OF BLOOD FLOW 1 0.0026
149 CHEMICAL BURN 3 0.0026
150 LIP OEDEMA 11 0.0026
151 BREAST FEEDING 2 0.0026
152 LUNG CYST 1 0.0025
153 ORAL PAIN 57 0.0025
154 BRONCHOPULMONARY DYSPLASIA 2 0.0025
155 SKIN CHAPPED 1 0.0025
156 TONGUE ERYTHEMA 2 0.0024
157 TENDERNESS 25 0.0024
158 CORNEAL DYSTROPHY 1 0.0024
159 PRODUCT PHYSICAL CONSISTENCY ISSUE 13 0.0023
160 PSEUDOMONAL BACTERAEMIA 2 0.0023
161 TONGUE PRURITUS 2 0.0023
162 GINGIVAL ERYTHEMA 2 0.0023
163 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
164 FACIAL PAIN 20 0.0022
165 ENLARGED UVULA 1 0.0022
166 CAECITIS 1 0.0022
167 RIGHT VENTRICULAR HYPERTROPHY 2 0.0022
168 NASAL OEDEMA 4 0.0022
169 BIOPSY BONE MARROW ABNORMAL 1 0.0022
170 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 393 0.0022
171 INCISION SITE ERYTHEMA 1 0.0022
172 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
173 VASCULAR INJURY 3 0.0021
174 BLOOD CREATINE ABNORMAL 1 0.0021
175 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0021
176 ENCEPHALITIS HERPES 1 0.0020
177 BLISTER 112 0.0020
178 LEUKOPLAKIA ORAL 1 0.0019
179 BLADDER OBSTRUCTION 1 0.0019
180 POLYOMAVIRUS VIRAEMIA 2 0.0019
181 GINGIVAL DISCOLOURATION 1 0.0019
182 BLOOD GASES ABNORMAL 1 0.0019
183 MARITAL PROBLEM 1 0.0019
184 APPLICATION SITE RASH 25 0.0018
185 MILK ALLERGY 1 0.0018
186 BONE FRAGMENTATION 1 0.0018
187 LIFE EXPECTANCY SHORTENED 1 0.0018
188 LIP ULCERATION 2 0.0017
189 AMBLYOPIA 1 0.0017
190 THERMAL BURN 12 0.0017
191 INDURATION 3 0.0017
192 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12 0.0017
193 ENDOSCOPY 1 0.0017
194 HYPERSENSITIVITY 310 0.0017
195 INFUSION SITE WARMTH 2 0.0016
196 BLOOD BLISTER 5 0.0016
197 NASAL PRURITUS 2 0.0016
198 MONOCLONAL GAMMOPATHY 1 0.0016
199 MUCOSAL DISCOLOURATION 1 0.0016
200 CHANGE IN SEIZURE PRESENTATION 1 0.0015
201 EAR PAIN 30 0.0015
202 NASAL CRUSTING 1 0.0015
203 ALLERGIC OEDEMA 1 0.0015
204 CHONDROCALCINOSIS 1 0.0015
205 ADVERSE REACTION 20 0.0015
206 PHOTOPHOBIA 28 0.0015
207 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
208 ANGULAR CHEILITIS 1 0.0014
209 BURNING SENSATION 101 0.0014
210 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
211 FACIAL PALSY 3 0.0014
212 WOUND HAEMORRHAGE 5 0.0014
213 THINKING ABNORMAL 25 0.0013
214 SOFT TISSUE INJURY 1 0.0013
215 MOUTH INJURY 2 0.0013
216 ORAL PRURITUS 3 0.0013
217 APHTHOUS STOMATITIS 3 0.0013
218 BLISTER INFECTED 1 0.0013
219 PLACENTA PRAEVIA 1 0.0013
220 EYELID FUNCTION DISORDER 1 0.0013
221 POST-TRAUMATIC NECK SYNDROME 1 0.0012
222 ORAL DISORDER 9 0.0012
223 CHEMICAL INJURY 1 0.0012
224 INTENTIONAL DEVICE USE ISSUE 1 0.0012
225 PURULENT DISCHARGE 5 0.0012
226 CERVICAL SPINAL STENOSIS 2 0.0012
227 DEVICE LOOSENING 1 0.0012
228 GENITAL BURNING SENSATION 1 0.0012
229 INFUSION SITE DISCOLOURATION 1 0.0011
230 GINGIVAL SWELLING 5 0.0011
231 SKIN HYPOPIGMENTATION 2 0.0011
232 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 62 0.0011
233 ANOGENITAL WARTS 1 0.0011
234 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
235 SALIVA ALTERED 1 0.0011
236 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
237 LOCAL SWELLING 19 0.0011
238 PNEUMONIA KLEBSIELLA 2 0.0011
239 BIOPSY 1 0.0011
240 AURA 2 0.0011
241 NASAL OBSTRUCTION 2 0.0011
242 LACERATION 10 0.0011
243 APPLICATION SITE BRUISE 1 0.0010
244 SPUTUM RETENTION 1 0.0010
245 WOUND 28 0.0010
246 PRODUCT USE ISSUE 187 0.0010
247 SNEEZING 22 0.0010
248 SKIN INDURATION 2 0.0010
249 AXILLARY MASS 1 0.0010
250 OEDEMA MUCOSAL 1 0.0010
251 DEVICE CONNECTION ISSUE 2 0.0009
252 STRESS URINARY INCONTINENCE 1 0.0009
253 GALLBLADDER ENLARGEMENT 1 0.0009
254 PILOERECTION 1 0.0009
255 IMPAIRED HEALING 30 0.0009
256 CORNEAL DISORDER 2 0.0009
257 TONGUE BLISTERING 2 0.0009
258 OPEN WOUND 1 0.0009
259 PHARMACEUTICAL PRODUCT COMPLAINT 23 0.0009
260 ACCIDENTAL EXPOSURE TO PRODUCT 91 0.0009
261 PRODUCT USE IN UNAPPROVED INDICATION 217 0.0009
262 VIITH NERVE PARALYSIS 3 0.0009
263 ADMINISTRATION SITE PAIN 1 0.0009
264 SURGICAL FAILURE 1 0.0009
265 INTERCEPTED MEDICATION ERROR 4 0.0009
266 PRURITUS ALLERGIC 1 0.0009
267 ESCHERICHIA BACTERAEMIA 2 0.0008
268 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
269 GLOSSITIS 3 0.0008
270 BLEEDING TIME PROLONGED 1 0.0008
271 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
272 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
273 TENSION 5 0.0008
274 BREECH PRESENTATION 1 0.0008
275 OSTEITIS 2 0.0008
276 TESTICULAR SWELLING 1 0.0008
277 SKIN DISORDER 26 0.0008
278 DACRYOSTENOSIS ACQUIRED 1 0.0008
279 APHTHOUS ULCER 6 0.0008
280 ORAL INFECTION 3 0.0008
281 PHARYNGEAL ULCERATION 1 0.0008
282 PHARYNGOLARYNGEAL PAIN 4 0.0008
283 BODY MASS INDEX INCREASED 1 0.0007
284 SIALOADENITIS 1 0.0007
285 CARBON DIOXIDE INCREASED 1 0.0007
286 SKIN DEPIGMENTATION 1 0.0007
287 DRUG EFFECT INCOMPLETE 26 0.0007
288 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
289 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
290 CULTURE URINE POSITIVE 1 0.0007
291 CHORIORETINOPATHY 1 0.0007
292 GENITAL RASH 1 0.0007
293 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
294 NONINFECTIVE GINGIVITIS 1 0.0007
295 INTESTINAL OBSTRUCTION 26 0.0007
296 NAIL DISORDER 6 0.0007
297 PULMONARY PAIN 2 0.0007
298 TOOTH DISCOLOURATION 2 0.0007
299 STRIDOR 2 0.0007
300 GENITAL PAIN 1 0.0007
301 CONJUNCTIVITIS ALLERGIC 1 0.0007
302 AXILLARY PAIN 1 0.0007
303 IMPETIGO 1 0.0007
304 ORAL MUCOSAL EXFOLIATION 1 0.0007
305 HEAT STROKE 1 0.0007
306 ORAL MUCOSAL ERUPTION 1 0.0007
307 CALCULUS URINARY 1 0.0006
308 PREMATURE SEPARATION OF PLACENTA 1 0.0006
309 DAYDREAMING 1 0.0006
310 ORAL MUCOSAL ERYTHEMA 1 0.0006
311 BACTERIAL VAGINOSIS 1 0.0006
312 PHARYNGEAL PARAESTHESIA 1 0.0006
313 MEDICATION RESIDUE PRESENT 3 0.0006
314 GINGIVAL PAIN 5 0.0006
315 NASAL ULCER 1 0.0006
316 SUBCUTANEOUS ABSCESS 3 0.0006
317 BACTERIAL SEPSIS 2 0.0006
318 INCORRECT DOSAGE ADMINISTERED 3 0.0006
319 OSTEOARTHRITIS 26 0.0006
320 HYPERAESTHESIA 5 0.0006
321 INFUSION SITE HAEMORRHAGE 2 0.0006
322 EXPOSURE DURING BREAST FEEDING 2 0.0006
323 SKIN INJURY 2 0.0006
324 EXPIRED DEVICE USED 2 0.0006
325 ARTHROPOD STING 1 0.0006
326 ERYTHEMA 122 0.0006
327 DRUG TOLERANCE 3 0.0006
328 EYE SWELLING 22 0.0006
329 SPLEEN DISORDER 1 0.0006
330 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 42 0.0006
331 SKIN WOUND 1 0.0006
332 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
333 MILIARIA 1 0.0006
334 SENSITIVITY OF TEETH 1 0.0006
335 INFUSION SITE DISCHARGE 1 0.0006
336 EAR PRURITUS 2 0.0006
337 IMPRISONMENT 1 0.0006
338 FEAR OF DISEASE 1 0.0006
339 PRODUCT DELIVERY MECHANISM ISSUE 3 0.0006
340 PRODUCT TAMPERING 1 0.0006
341 PRODUCT RESIDUE PRESENT 3 0.0006
342 OBSESSIVE THOUGHTS 1 0.0006
343 SOFT TISSUE INFECTION 1 0.0005
344 ESSENTIAL HYPERTENSION 1 0.0005
345 MOUTH HAEMORRHAGE 4 0.0005
346 SWOLLEN TONGUE 17 0.0005
347 RHINORRHOEA 35 0.0005
348 LYMPH NODE PAIN 1 0.0005
349 HERPES VIRUS INFECTION 3 0.0005
350 MOTION SICKNESS 1 0.0005
351 INTERSTITIAL LUNG DISEASE 25 0.0005
352 ANAPHYLACTIC REACTION 28 0.0005
353 PATENT DUCTUS ARTERIOSUS 2 0.0005
354 OBSTRUCTION 2 0.0005
355 SENSORY DISTURBANCE 8 0.0005
356 NECK PAIN 27 0.0005
357 EMBOLISM 4 0.0005
358 ACCIDENTAL EXPOSURE 2 0.0005
359 PHYSICAL ASSAULT 1 0.0005
360 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
361 EAR SWELLING 1 0.0005
362 TONGUE DISCOMFORT 2 0.0005
363 PRODUCT DISPENSING ISSUE 2 0.0005
364 INFUSION SITE PAIN 6 0.0005
365 ABNORMAL SENSATION IN EYE 2 0.0005
366 INFUSION SITE BRUISING 1 0.0005
367 OEDEMA 25 0.0005
368 CERVICAL DYSPLASIA 1 0.0005
369 LIMB MASS 1 0.0005
370 PHARYNGEAL OEDEMA 7 0.0005
371 GASTROINTESTINAL ULCER 1 0.0005
372 PRODUCT LOT NUMBER ISSUE 1 0.0005
373 SWELLING 42 0.0004
374 ADENOCARCINOMA 1 0.0004
375 APPLICATION SITE URTICARIA 1 0.0004
376 RENAL COLIC 1 0.0004
377 WHEEZING 26 0.0004
378 EYELID DISORDER 1 0.0004
379 INFUSION SITE INFECTION 1 0.0004
380 SKIN ULCER 11 0.0004
381 SKIN TIGHTNESS 2 0.0004
382 PRURITUS GENITAL 1 0.0004
383 LYMPHADENOPATHY 15 0.0004
384 EATING DISORDER 9 0.0004
385 PUSTULE 1 0.0004
386 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
387 PRODUCT PACKAGING ISSUE 4 0.0004
388 STARING 1 0.0004
389 LYMPHADENITIS 1 0.0004
390 ADVERSE DRUG REACTION 37 0.0004
391 ILL-DEFINED DISORDER 25 0.0004
392 SKIN FISSURES 8 0.0004
393 CARTILAGE INJURY 1 0.0004
394 INSTILLATION SITE PAIN 1 0.0004
395 SUFFOCATION FEELING 1 0.0004
396 SUNBURN 3 0.0004
397 EXPOSURE DURING PREGNANCY 25 0.0004
398 RASH MACULAR 14 0.0004
399 STEM CELL TRANSPLANT 1 0.0004
400 HYPERPARATHYROIDISM SECONDARY 1 0.0004
401 STOMATITIS 24 0.0004
402 LABYRINTHITIS 1 0.0004
403 BRAIN ABSCESS 1 0.0004
404 EXCORIATION 1 0.0004
405 SKIN IRRITATION 18 0.0004
406 INCREASED UPPER AIRWAY SECRETION 2 0.0004
407 MEDICATION RESIDUE 1 0.0004
408 PARAESTHESIA 61 0.0004
409 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
410 HYPOAESTHESIA 58 0.0004
411 TOOTHACHE 7 0.0004
412 FURUNCLE 3 0.0004
413 ANGIONEUROTIC OEDEMA 1 0.0004
414 GINGIVITIS 2 0.0004
415 CHONDROPATHY 1 0.0004
416 ADVERSE EVENT 34 0.0004
417 ORAL FUNGAL INFECTION 1 0.0004
418 HEART RATE ABNORMAL 2 0.0004
419 HALLUCINATION 27 0.0004
420 LUNG CONSOLIDATION 1 0.0004
421 INFUSION SITE ERYTHEMA 3 0.0004
422 SKIN HYPERTROPHY 1 0.0004
423 FACE OEDEMA 6 0.0004
424 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
425 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
426 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
427 JOINT LOCK 1 0.0004
428 PRODUCT CONTAINER ISSUE 3 0.0003
429 VENTRICULAR SEPTAL DEFECT 2 0.0003
430 RASH 152 0.0003
431 SKIN HAEMORRHAGE 5 0.0003
432 PALLOR 9 0.0003
433 EMERGENCY CARE 1 0.0003
434 EYE INJURY 1 0.0003
435 KERATITIS 1 0.0003
436 MASTICATION DISORDER 1 0.0003
437 EYELIDS PRURITUS 1 0.0003
438 SWELLING OF EYELID 2 0.0003
439 INFUSION SITE SWELLING 2 0.0003
440 PAIN IN JAW 9 0.0003
441 OCULAR HYPERAEMIA 15 0.0003
442 DYSPHAGIA 30 0.0003
443 GLOSSODYNIA 7 0.0003
444 MUSCLE TIGHTNESS 5 0.0003
445 SPEECH DISORDER 16 0.0003
446 PRURITUS 115 0.0003
447 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
448 POTENTIATING DRUG INTERACTION 1 0.0003
449 DRUG EFFECT DECREASED 16 0.0003
450 MUSCULOSKELETAL STIFFNESS 26 0.0003
451 NEOPLASM RECURRENCE 1 0.0003
452 PUSTULAR PSORIASIS 1 0.0003
453 CONTUSION 28 0.0003
454 MEDICATION ERROR 16 0.0003
455 DERMATITIS 6 0.0003
456 MOUTH ULCERATION 6 0.0003
457 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
458 SKIN DISCOLOURATION 13 0.0003
459 CHILLS 33 0.0003
460 FIBRIN D DIMER INCREASED 1 0.0003
461 FRUSTRATION 1 0.0003
462 PRURITUS GENERALISED 6 0.0003
463 BONE LESION 1 0.0003
464 RENAL TRANSPLANT 1 0.0003
465 PARADOXICAL DRUG REACTION 1 0.0003
466 DRY SKIN 36 0.0003
467 DRUG INTOLERANCE 26 0.0003
468 DRUG EXPOSURE DURING PREGNANCY 9 0.0003
469 PARANASAL SINUS DISCOMFORT 1 0.0003
470 DERMATITIS CONTACT 3 0.0003
471 PROCEDURAL COMPLICATION 2 0.0003
472 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
473 APNOEA 2 0.0003
474 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
475 NAIL DISCOLOURATION 1 0.0003
476 OESOPHAGEAL PAIN 1 0.0003
477 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
478 NASAL DISCOMFORT 2 0.0003
479 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
480 CANDIDIASIS 1 0.0002
481 EYE PAIN 14 0.0002
482 PRODUCT ADMINISTRATION ERROR 5 0.0002
483 RHEUMATOID ARTHRITIS 28 0.0002
484 FEEDING DISORDER 5 0.0002
485 URTICARIA 41 0.0002
486 EYE IRRITATION 14 0.0002
487 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
488 ATRIAL SEPTAL DEFECT 2 0.0002
489 SENSATION OF FOREIGN BODY 2 0.0002
490 CARDIAC FAILURE CHRONIC 1 0.0002
491 ALCOHOLISM 1 0.0002
492 DEVICE OPERATIONAL ISSUE 1 0.0002
493 POOR QUALITY SLEEP 5 0.0002
494 HORDEOLUM 1 0.0002
495 MONOPLEGIA 1 0.0002
496 MELANOCYTIC NAEVUS 1 0.0002
497 DYSPHEMIA 1 0.0002
498 ONYCHOMYCOSIS 1 0.0002
499 TOOTH INFECTION 3 0.0002
500 PARONYCHIA 1 0.0002
501 INTENTIONAL DEVICE MISUSE 1 0.0002
502 LIGAMENT RUPTURE 1 0.0002
503 VISUAL IMPAIRMENT 28 0.0002
504 BLOOD CREATINE INCREASED 1 0.0002
505 QUALITY OF LIFE DECREASED 3 0.0002
506 IRON DEFICIENCY 1 0.0002
507 OROPHARYNGEAL DISCOMFORT 2 0.0002
508 LIMB INJURY 6 0.0002
509 GINGIVAL BLEEDING 3 0.0002
510 LOSS OF CONSCIOUSNESS 28 0.0002
511 EAR DISORDER 1 0.0002
512 SYNOVIAL CYST 1 0.0002
513 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
514 BACTERIAL INFECTION 4 0.0002
515 SQUAMOUS CELL CARCINOMA 2 0.0002
516 SKIN ABRASION 1 0.0002
517 COLITIS MICROSCOPIC 1 0.0002
518 GESTATIONAL DIABETES 1 0.0002
519 SKIN BURNING SENSATION 15 0.0002
520 EYE PRURITUS 7 0.0002
521 HYPERCHOLESTEROLAEMIA 2 0.0002
522 JOINT SWELLING 25 0.0002
523 PAIN 127 0.0002
524 MUCOUS STOOLS 1 0.0002
525 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
526 ACNE 15 0.0002
527 KLEBSIELLA INFECTION 1 0.0002
528 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
529 EYELID PTOSIS 2 0.0002
530 DISCOMFORT 12 0.0002
531 INITIAL INSOMNIA 2 0.0002
532 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
533 EYE DISCHARGE 2 0.0002
534 BASAL CELL CARCINOMA 3 0.0002
535 ANORECTAL DISCOMFORT 1 0.0002
536 JOINT INJURY 4 0.0002
537 FOOD POISONING 1 0.0002
538 INFECTION 27 0.0002
539 OVERWEIGHT 1 0.0002
540 DRY MOUTH 15 0.0002
541 THROAT TIGHTNESS 5 0.0002
542 BLOOD POTASSIUM INCREASED 3 0.0002
543 JAW DISORDER 1 0.0002
544 PROSTATIC DISORDER 1 0.0002
545 CYSTIC FIBROSIS 1 0.0002
546 STREPTOCOCCAL INFECTION 1 0.0002
547 ABDOMINAL DISCOMFORT 30 0.0002
548 MALNUTRITION 2 0.0002
549 OCULAR DISCOMFORT 2 0.0002
550 SKIN EXFOLIATION 15 0.0002
551 EYE INFECTION 2 0.0002
552 PERIORBITAL SWELLING 1 0.0002
553 PREMATURE LABOUR 1 0.0002
554 PERONEAL NERVE PALSY 1 0.0002
555 DYSGEUSIA 13 0.0002
556 CONSTIPATION 38 0.0002
557 SKIN ATROPHY 1 0.0002
558 PRODUCT STORAGE ERROR 15 0.0002
559 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
560 PLEURISY 1 0.0002
561 SINUS HEADACHE 1 0.0002
562 CARDIAC PACEMAKER INSERTION 1 0.0002
563 HYPERLIPIDAEMIA 2 0.0002
564 PROTHROMBIN TIME PROLONGED 1 0.0002
565 GAIT DISTURBANCE 32 0.0002
566 SYMPTOM RECURRENCE 1 0.0002
567 HEARING IMPAIRED 1 0.0002
568 APHASIA 5 0.0002
569 PIGMENTATION DISORDER 1 0.0002
570 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
571 TOOTH EXTRACTION 2 0.0002
572 INFUSION SITE EXTRAVASATION 1 0.0002
573 NASAL DRYNESS 1 0.0002
574 MULTIPLE INJURIES 1 0.0002
575 FOREIGN BODY SENSATION IN EYES 1 0.0002
576 THROAT IRRITATION 7 0.0002
577 HAEMOGLOBIN ABNORMAL 1 0.0002
578 RASH GENERALISED 4 0.0002
579 TENDON DISORDER 1 0.0002
580 PULMONARY CONGESTION 2 0.0002
581 CORONAVIRUS INFECTION 1 0.0002
582 SPINAL FRACTURE 3 0.0001
583 CHOLECYSTITIS CHRONIC 1 0.0001
584 BREAST MASS 1 0.0001
585 FEAR 4 0.0001
586 INTENTIONAL PRODUCT MISUSE 13 0.0001
587 SINUS CONGESTION 2 0.0001
588 MYALGIA 25 0.0001
589 BODY TEMPERATURE INCREASED 3 0.0001
590 SKIN LESION 4 0.0001
591 ONYCHOCLASIS 1 0.0001
592 RESPIRATION ABNORMAL 1 0.0001
593 JOINT EFFUSION 1 0.0001
594 FORMICATION 1 0.0001
595 DEVICE OCCLUSION 2 0.0001
596 SKIN REACTION 2 0.0001
597 PAPULE 1 0.0001
598 PANIC REACTION 1 0.0001
599 PRODUCT DISPENSING ERROR 3 0.0001
600 RASH PUSTULAR 1 0.0001
601 BLINDNESS TRANSIENT 1 0.0001
602 PSYCHIATRIC SYMPTOM 1 0.0001
603 ARTHROPOD BITE 1 0.0001
604 FEELING DRUNK 1 0.0001
605 RASH PAPULAR 3 0.0001
606 GENERAL SYMPTOM 1 0.0001
607 LACRIMATION INCREASED 4 0.0001
608 ECONOMIC PROBLEM 2 0.0001
609 OSTEOPENIA 2 0.0001
610 HYPERTHERMIA 1 0.0001
611 INSURANCE ISSUE 2 0.0001
612 FOOD ALLERGY 1 0.0001
613 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
614 HEADACHE 80 0.0001
615 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
616 PRODUCT USE COMPLAINT 2 0.0001
617 DIZZINESS 63 0.0001
618 ULCER 2 0.0001
619 ABSCESS 2 0.0001
620 BLOOD PRESSURE FLUCTUATION 3 0.0001
621 BACK PAIN 29 0.0001
622 ABDOMINAL PAIN 29 0.0001
623 SENSORY LOSS 1 0.0001
624 LOCALISED INFECTION 3 0.0001
625 BACK DISORDER 2 0.0001
626 POST PROCEDURAL INFECTION 1 0.0001
627 DECUBITUS ULCER 1 0.0001
628 INJECTION SITE URTICARIA 3 0.0001
629 VIRAL INFECTION 4 0.0001
630 FUNGAL INFECTION 4 0.0001
631 OFF LABEL USE 105 0.0001
632 LIVE BIRTH 1 0.0001
633 CELLULITIS 6 0.0001
634 WEIGHT DECREASED 33 0.0001
635 SINUSITIS 12 0.0001
636 MUSCULOSKELETAL DISCOMFORT 2 0.0001
637 MUSCLE STRAIN 1 0.0001
638 CARDIAC MURMUR 1 0.0001
639 PYELONEPHRITIS 1 0.0001
640 SKIN SWELLING 1 0.0001
641 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
642 HAEMORRHAGE 12 0.0001
643 FEELING HOT 7 0.0001
644 ANHEDONIA 3 0.0001
645 EAR INFECTION 3 0.0001
646 RESPIRATORY RATE INCREASED 1 0.0001
647 THERAPY NON-RESPONDER 5 0.0001
648 GASTROENTERITIS VIRAL 2 0.0001
649 OSTEOMYELITIS 2 0.0001
650 PNEUMONIA BACTERIAL 1 0.0001
651 INCREASED TENDENCY TO BRUISE 1 0.0001
652 NERVE COMPRESSION 1 0.0001
653 FEELING COLD 3 0.0001
654 ERYTHEMA MULTIFORME 1 0.0001
655 HAEMOGLOBIN DECREASED 11 0.0001
656 NEPHROPATHY 1 0.0001
657 DEFORMITY 1 0.0001
658 FLANK PAIN 1 0.0001
659 FOOT FRACTURE 2 0.0001
660 RECALLED PRODUCT ADMINISTERED 1 0.0001
661 EYE INFLAMMATION 1 0.0001
662 SLEEP APNOEA SYNDROME 2 0.0001
663 RASH ERYTHEMATOUS 5 0.0001
664 VOMITING 49 0.0001
665 ASTHENIA 39 0.0001
666 ATELECTASIS 1 0.0001
667 DIZZINESS POSTURAL 1 0.0001
668 PHARYNGEAL SWELLING 1 0.0001
669 ASCITES 3 0.0001
670 HEPATOMEGALY 1 0.0001
671 LIGAMENT SPRAIN 1 0.0001
672 SINUS DISORDER 2 0.0001
673 BLADDER DISORDER 1 0.0001
674 DYSPNOEA 57 0.0001
675 OVARIAN CYST 1 0.0001
676 PRODUCT PHYSICAL ISSUE 2 0.0001
677 EXTRA DOSE ADMINISTERED 4 0.0001
678 DRY THROAT 1 0.0001
679 SLUGGISHNESS 1 0.0001
680 EAR DISCOMFORT 1 0.0001
681 HELICOBACTER INFECTION 1 0.0001
682 OROPHARYNGEAL PAIN 9 0.0001
683 INFLAMMATION 5 0.0001
684 POOR VENOUS ACCESS 1 0.0001
685 FEELING ABNORMAL 23 0.0001
686 PETECHIAE 1 0.0001
687 INJECTION SITE DISCOMFORT 1 0.0001
688 SCRATCH 1 0.0001
689 HYPOTHYROIDISM 3 0.0001
690 IMPAIRED WORK ABILITY 2 0.0001
691 BODY HEIGHT DECREASED 1 0.0001
692 IRRITABLE BOWEL SYNDROME 2 0.0001
693 NASOPHARYNGITIS 17 0.0001
694 EYE DISORDER 3 0.0001
695 DENTAL CARIES 1 0.0001
696 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
697 SKIN INFECTION 1 0.0001
698 BLOOD CALCIUM DECREASED 1 0.0001
699 CHROMATURIA 2 0.0001
700 REBOUND EFFECT 1 0.0001
701 DIARRHOEA 57 0.0001
702 MICTURITION URGENCY 1 0.0001
703 CHOLECYSTECTOMY 1 0.0001
704 MADAROSIS 1 0.0001
705 EYELID OEDEMA 1 0.0001
706 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
707 DYSPHONIA 5 0.0001
708 COVID-19 PNEUMONIA 1 0.0001
709 BACTERAEMIA 1 0.0001
710 ARTHRALGIA 35 0.0001
711 DISEASE RECURRENCE 4 0.0001
712 PRODUCT PRESCRIBING ERROR 2 0.0001
713 CHOLECYSTITIS 1 0.0001
714 INCORRECT DOSE ADMINISTERED 19 0.0001
715 THERAPEUTIC RESPONSE DECREASED 5 0.0001
716 BURSITIS 1 0.0001
717 NOCTURIA 1 0.0001
718 NO THERAPEUTIC RESPONSE 1 0.0001
719 SMALL INTESTINAL OBSTRUCTION 1 0.0001
720 INJECTION SITE MASS 3 0.0001
721 PHARYNGITIS 1 0.0001
722 CYST 1 0.0001
723 HAIR COLOUR CHANGES 1 0.0001
724 AGEUSIA 2 0.0001
725 SECRETION DISCHARGE 1 0.0001
726 POISONING 1 0.0001
727 MUSCLE ATROPHY 1 0.0001
728 ROTATOR CUFF SYNDROME 1 0.0001
729 ILLNESS 8 0.0001
730 ANOREXIA 1 0.0001
731 PALPITATIONS 9 0.0001
732 NODULE 1 0.0001
733 NERVOUSNESS 4 0.0001
734 MUCOSAL INFLAMMATION 2 0.0001
735 JOINT STIFFNESS 2 0.0001
736 IMMUNE SYSTEM DISORDER 1 0.0001
737 EYE HAEMORRHAGE 1 0.0001
738 JOINT RANGE OF MOTION DECREASED 1 0.0001
739 PAIN OF SKIN 2 0.0001
740 PRODUCT TASTE ABNORMAL 1 0.0001
741 ANXIETY 21 0.0001
742 IMPAIRED GASTRIC EMPTYING 1 0.0001
743 NAUSEA 58 0.0001
744 FATIGUE 57 0.0001
745 TREATMENT NONCOMPLIANCE 4 0.0001
746 PERIPHERAL COLDNESS 1 0.0001
747 CARPAL TUNNEL SYNDROME 1 0.0001
748 SEASONAL ALLERGY 1 0.0001
749 SINUS TACHYCARDIA 1 0.0001
750 HYPERTHYROIDISM 1 0.0001
751 SEPTIC SHOCK 3 0.0001
752 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
753 LIVER FUNCTION TEST ABNORMAL 2 0.0001
754 UNDERDOSE 5 0.0001
755 LIVER DISORDER 3 0.0001
756 DEHYDRATION 9 0.0001
757 IMMUNODEFICIENCY 1 0.0001
758 IRRITABILITY 4 0.0001
759 BLOOD POTASSIUM DECREASED 2 0.0001
760 PYREXIA 23 0.0001
761 HIP ARTHROPLASTY 1 0.0001
762 INJECTION SITE SWELLING 5 0.0001
763 LYMPHOMA 1 0.0001
764 MUSCULOSKELETAL CHEST PAIN 1 0.0001
765 TENDONITIS 1 0.0001
766 BLOOD CHOLESTEROL INCREASED 3 0.0001
767 ARRHYTHMIA 3 0.0001
768 RESPIRATORY TRACT CONGESTION 1 0.0001
769 HALLUCINATION, AUDITORY 1 0.0001
770 MIGRAINE 6 0.0001
771 CYSTITIS 2 0.0001
772 SCIATICA 1 0.0001
773 MOVEMENT DISORDER 2 0.0001
774 NIGHT SWEATS 2 0.0001
775 DEEP VEIN THROMBOSIS 4 0.0001
776 METASTASES TO BONE 1 0.0001
777 PHOTOSENSITIVITY REACTION 1 0.0001
778 BLOOD PRESSURE DECREASED 4 0.0001
779 URINARY RETENTION 2 0.0001
780 GAIT INABILITY 2 0.0001
781 INJECTION SITE PRURITUS 4 0.0001
782 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
783 CANDIDA INFECTION 1 0.0001
784 HEMIPARESIS 1 0.0001
785 PERIPHERAL SWELLING 9 0.0001
786 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
787 GASTRIC DISORDER 2 0.0001
788 EMOTIONAL DISTRESS 7 0.0001
789 DEVICE USE ISSUE 1 0.0001
790 HEART RATE DECREASED 2 0.0001
791 INJURY 4 0.0001
792 DEPRESSED MOOD 3 0.0001
793 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
794 HEAD DISCOMFORT 1 0.0001
795 INSOMNIA 15 0.0001
796 GOUT 1 0.0001
797 NO ADVERSE EVENT 10 0.0001
798 BONE DISORDER 1 0.0001
799 END STAGE RENAL DISEASE 1 0.0001
800 MUSCLE SPASMS 10 0.0001
801 CONJUNCTIVITIS 1 0.0001
802 PANCYTOPENIA 3 0.0001
803 MIDDLE INSOMNIA 1 0.0001
804 COUGH 15 0.0001
805 OXYGEN SATURATION DECREASED 3 0.0001
806 UNEVALUABLE EVENT 4 0.0001
807 GASTRIC ULCER 1 0.0001
808 FEELING JITTERY 1 0.0001
809 ACUTE RESPIRATORY FAILURE 1 0.0001
810 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
811 ERUCTATION 1 0.0001
812 HAEMORRHOIDS 1 0.0001
813 VISION BLURRED 7 0.0001
814 KIDNEY INFECTION 1 0.0001
815 ARTHRITIS 4 0.0001
816 DISABILITY 1 0.0001
817 HAEMATOCRIT DECREASED 1 0.0001
818 BLOOD PRESSURE ABNORMAL 1 0.0001
819 MALAISE 22 0.0001
820 VERTIGO 3 0.0000
821 DYSKINESIA 2 0.0000
822 INJURY ASSOCIATED WITH DEVICE 1 0.0000
823 PRODUCT PREPARATION ERROR 1 0.0000
824 RIB FRACTURE 1 0.0000
825 TREMOR 8 0.0000
826 PULMONARY HYPERTENSION 1 0.0000
827 RENAL IMPAIRMENT 4 0.0000
828 RETCHING 1 0.0000
829 URINARY TRACT INFECTION 8 0.0000
830 RECTAL HAEMORRHAGE 2 0.0000
831 SKIN CANCER 1 0.0000
832 VAGINAL HAEMORRHAGE 2 0.0000
833 MENTAL DISORDER 2 0.0000
834 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
835 DEVICE DIFFICULT TO USE 3 0.0000
836 FEBRILE NEUTROPENIA 3 0.0000
837 TACHYCARDIA 4 0.0000
838 COLITIS ULCERATIVE 2 0.0000
839 GASTROINTESTINAL DISORDER 4 0.0000
840 ASTHMA 5 0.0000
841 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
842 MUSCLE TWITCHING 1 0.0000
843 SEIZURE 5 0.0000
844 PERICARDIAL EFFUSION 1 0.0000
845 CHEST PAIN 8 0.0000
846 COGNITIVE DISORDER 2 0.0000
847 PRODUCTIVE COUGH 2 0.0000
848 CEREBROVASCULAR ACCIDENT 7 0.0000
849 MENTAL IMPAIRMENT 1 0.0000
850 RESPIRATORY FAILURE 3 0.0000
851 NEURALGIA 1 0.0000
852 AGITATION 3 0.0000
853 LUNG DISORDER 2 0.0000
854 LIVER INJURY 1 0.0000
855 BRONCHITIS 3 0.0000
856 HEART RATE INCREASED 4 0.0000
857 INJECTION SITE ERYTHEMA 5 0.0000
858 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
859 DRY EYE 2 0.0000
860 PNEUMONIA ASPIRATION 1 0.0000
861 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
862 HYPOPHAGIA 1 0.0000
863 ANAPHYLACTIC SHOCK 1 0.0000
864 EXPOSURE VIA SKIN CONTACT 1 0.0000
865 DIPLOPIA 1 0.0000
866 RESPIRATORY TRACT INFECTION 1 0.0000
867 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
868 INJECTION SITE HAEMORRHAGE 3 0.0000
869 PAIN IN EXTREMITY 11 0.0000
870 FREQUENT BOWEL MOVEMENTS 1 0.0000
871 RASH PRURITIC 2 0.0000
872 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
873 DIVERTICULITIS 1 0.0000
874 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
875 MUSCULAR WEAKNESS 4 0.0000
876 INTENTIONAL DOSE OMISSION 1 0.0000
877 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
878 HERPES ZOSTER 2 0.0000
879 LETHARGY 2 0.0000
880 DYSSTASIA 1 0.0000
881 COVID-19 6 0.0000
882 NASAL CONGESTION 2 0.0000
883 PSYCHOTIC DISORDER 1 0.0000
884 CATARACT 2 0.0000
885 DEVICE ISSUE 3 0.0000
886 HYPERTENSION 7 0.0000
887 OEDEMA PERIPHERAL 4 0.0000
888 SUICIDAL IDEATION 3 0.0000
889 INJECTION SITE PAIN 10 0.0000
890 EMOTIONAL DISORDER 1 0.0000
891 LIMB DISCOMFORT 1 0.0000
892 FEMUR FRACTURE 1 0.0000
893 NERVOUS SYSTEM DISORDER 1 0.0000
894 BONE DENSITY DECREASED 1 0.0000
895 METABOLIC ACIDOSIS 1 0.0000
896 HIP FRACTURE 1 0.0000
897 CONFUSIONAL STATE 5 0.0000
898 DEPRESSION 7 0.0000
899 AMNESIA 2 0.0000
900 PSORIASIS 4 0.0000
901 CHOLELITHIASIS 1 0.0000
902 DYSPEPSIA 3 0.0000
903 STAPHYLOCOCCAL INFECTION 1 0.0000
904 DRUG DOSE OMISSION 5 0.0000
905 DECREASED APPETITE 7 0.0000
906 NEOPLASM MALIGNANT 2 0.0000
907 ANGER 1 0.0000
908 FLUSHING 3 0.0000
909 HAEMATURIA 1 0.0000
910 INJECTION SITE REACTION 2 0.0000
911 NIGHTMARE 1 0.0000
912 DEVICE USE ERROR 1 0.0000
913 NEOPLASM PROGRESSION 1 0.0000
914 ABDOMINAL DISTENSION 3 0.0000
915 SLEEP DISORDER 2 0.0000
916 MOBILITY DECREASED 2 0.0000
917 PNEUMONIA 9 0.0000
918 PANIC ATTACK 1 0.0000
919 DYSURIA 1 0.0000
920 INFLUENZA 3 0.0000
921 SEPSIS 3 0.0000
922 WEIGHT INCREASED 6 0.0000
923 EPISTAXIS 2 0.0000
924 DYSARTHRIA 1 0.0000
925 CHRONIC KIDNEY DISEASE 2 0.0000
926 HOSPITALISATION 4 0.0000
927 DISEASE PROGRESSION 3 0.0000
928 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
929 ABNORMAL BEHAVIOUR 1 0.0000
930 CARDIAC FAILURE CONGESTIVE 2 0.0000
931 DRUG DEPENDENCE 4 0.0000
932 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
933 PSORIATIC ARTHROPATHY 1 0.0000
934 BLINDNESS 1 0.0000
935 OSTEOPOROSIS 1 0.0000
936 INFLUENZA LIKE ILLNESS 2 0.0000
937 FALL 8 0.0000
938 POLLAKIURIA 1 0.0000
939 ROAD TRAFFIC ACCIDENT 1 0.0000
940 OVERDOSE 5 0.0000
941 BALANCE DISORDER 2 0.0000
942 DEVICE DISLOCATION 1 0.0000
943 RENAL FAILURE 3 0.0000
944 PULMONARY OEDEMA 1 0.0000
945 NEPHROLITHIASIS 1 0.0000
946 BLOOD GLUCOSE INCREASED 4 0.0000
947 PULMONARY EMBOLISM 2 0.0000
948 NEUROPATHY PERIPHERAL 2 0.0000
949 COMA 1 0.0000
950 MULTIPLE SCLEROSIS 1 0.0000
951 BLOOD GLUCOSE DECREASED 1 0.0000
952 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
953 HYPOGLYCAEMIA 1 0.0000
954 PRODUCT DOSE OMISSION ISSUE 6 0.0000
955 FLUID RETENTION 1 0.0000
956 BLOOD PRESSURE INCREASED 3 0.0000
957 ABDOMINAL PAIN UPPER 4 0.0000
958 ECZEMA 1 0.0000
959 PLATELET COUNT DECREASED 2 0.0000
960 HAEMATOCHEZIA 1 0.0000
961 ARTHROPATHY 1 0.0000
962 FLATULENCE 1 0.0000
963 CONVULSION 1 0.0000
964 BONE PAIN 1 0.0000
965 SURGERY 1 0.0000
966 PLEURAL EFFUSION 1 0.0000
967 INTENTIONAL OVERDOSE 1 0.0000
968 ALOPECIA 3 0.0000
969 INFUSION RELATED REACTION 1 0.0000
970 HYPOTENSION 3 0.0000
971 NEUTROPENIA 2 0.0000
972 MEMORY IMPAIRMENT 2 0.0000
973 DEVICE MALFUNCTION 1 0.0000
974 DIABETES MELLITUS 1 0.0000
975 DRUG INTERACTION 2 0.0000
976 INJECTION SITE BRUISING 1 0.0000
977 CARDIAC FAILURE 1 0.0000
978 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
979 DRUG ABUSE 1 0.0000
980 DRUG WITHDRAWAL SYNDROME 1 0.0000
981 BREAST CANCER 1 0.0000
982 CARDIAC DISORDER 1 0.0000
983 ATRIAL FIBRILLATION 1 0.0000
984 SYNCOPE 1 0.0000
985 SOMNOLENCE 2 0.0000
986 CHEST DISCOMFORT 1 0.0000
987 ACUTE KIDNEY INJURY 1 0.0000
988 MYOCARDIAL INFARCTION 1 0.0000
989 ANAEMIA 1 0.0000
990 DEATH 4 0.0000